title: Tolerability of HAART in patients treated during acute HIV infection.
authors.forename: Chrysoula
authors.initials: C
authors.lastname: Vlassi
authors.forename: Angela
authors.initials: A
authors.lastname: Corpolongo
authors.forename: Gianpiero
authors.initials: G
authors.lastname: D'Offizi
authors.forename: Paola
authors.initials: P
authors.lastname: Scognamiglio
authors.forename: Maria Flora
authors.initials: MF
authors.lastname: Salvatori
authors.forename: Rita
authors.initials: R
authors.lastname: Fezza
authors.forename: Pasquale
authors.initials: P
authors.lastname: Narciso
mesh_terms: D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects* / Q000379:methods*; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D028761:Withholding Treatment / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents